SH3GLB1 | SH3-domain GRB2-like endophilin B1 | Mitochondrial proteins
| | | | | Expressed in all |
CCBL2 | Cysteine conjugate-beta lyase 2 | Enzymes
| | | | | Expressed in all |
ZNF326 | Zinc finger protein 326 | | | | | | Expressed in all |
CDC7 | Cell division cycle 7 | Enzymes Plasma proteins
| | | | | Mixed |
DR1 | Down-regulator of transcription 1, TBP-binding (negative cofactor 2) | | | | | | Expressed in all |
GCLM | Glutamate-cysteine ligase, modifier subunit | Cancer-related genes
| | | | | Expressed in all |
CNN3 | Calponin 3, acidic | Plasma proteins
| | | | | Expressed in all |
DBT | Dihydrolipoamide branched chain transacylase E2 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
SARS | Seryl-tRNA synthetase | Enzymes Plasma proteins
| | | | | Expressed in all |
SORT1 | Sortilin 1 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
PSMA5 | Proteasome (prosome, macropain) subunit, alpha type, 5 | Enzymes Plasma proteins
| | | | | Expressed in all |
GSTM3 | Glutathione S-transferase mu 3 (brain) | Cancer-related genes Enzymes
| | | | | Expressed in all |
PHGDH | Phosphoglycerate dehydrogenase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
SV2A | Synaptic vesicle glycoprotein 2A | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
APH1A | APH1A gamma secretase subunit | Predicted membrane proteins
| | | | | Expressed in all |
CTSS | Cathepsin S | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
ARNT | Aryl hydrocarbon receptor nuclear translocator | Cancer-related genes Transcription factors
| | | | | Expressed in all |
PSMD4 | Proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 | Cancer-related genes
| | | | | Expressed in all |
PSMB4 | Proteasome (prosome, macropain) subunit, beta type, 4 | Enzymes Plasma proteins
| | | | | Expressed in all |
S100A10 | S100 calcium binding protein A10 | Predicted membrane proteins
| | | | | Expressed in all |
S100A11 | S100 calcium binding protein A11 | Plasma proteins
| | | | | Expressed in all |
FLG | Filaggrin | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enriched |
S100A6 | S100 calcium binding protein A6 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
S100A4 | S100 calcium binding protein A4 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
S100A14 | S100 calcium binding protein A14 | Plasma proteins
| | | | | Tissue enhanced |
S100A13 | S100 calcium binding protein A13 | | | | | | Expressed in all |
ILF2 | Interleukin enhancer binding factor 2 | Plasma proteins
| | | | | Expressed in all |
JTB | Jumping translocation breakpoint | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ADAR | Adenosine deaminase, RNA-specific | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
FLAD1 | Flavin adenine dinucleotide synthetase 1 | Enzymes
| | | | | Expressed in all |
MUC1 | Mucin 1, cell surface associated | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DAP3 | Death associated protein 3 | Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
LMNA | Lamin A/C | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
MEF2D | Myocyte enhancer factor 2D | Transcription factors
| | | | | Expressed in all |
NES | Nestin | Plasma proteins
| | | | | Tissue enhanced |
HDGF | Hepatoma-derived growth factor | Plasma proteins
| | | | | Expressed in all |
ARHGEF11 | Rho guanine nucleotide exchange factor (GEF) 11 | | | | | | Expressed in all |
IFI16 | Interferon, gamma-inducible protein 16 | Plasma proteins
| | | | | Expressed in all |
COPA | Coatomer protein complex, subunit alpha | Plasma proteins
| | | | | Expressed in all |
NCSTN | Nicastrin | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD48 | CD48 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
F11R | F11 receptor | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
UFC1 | Ubiquitin-fold modifier conjugating enzyme 1 | | | | | | Expressed in all |
CD247 | CD247 molecule | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
RCSD1 | RCSD domain containing 1 | | | | | | Mixed |
ATP1B1 | ATPase, Na+/K+ transporting, beta 1 polypeptide | Predicted membrane proteins Transporters
| | | | | Expressed in all |
PRDX6 | Peroxiredoxin 6 | Enzymes Plasma proteins
| | | | | Expressed in all |
SOAT1 | Sterol O-acyltransferase 1 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
GLUL | Glutamate-ammonia ligase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
DHX9 | DEAH (Asp-Glu-Ala-His) box helicase 9 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |